FDA suggests letting more patients with viral infections into cancer clinical trials

FDA suggests letting more patients with viral infections into cancer clinical trials

A draft guidance, not yet implemented, suggests allowing more patients with hepatitis B and C and HIV into oncology clinical trials from which they are currently excluded.

Source: https://ift.tt/2Tvpfiv